NCT02306941

Brief Summary

This pilot-study aims to evaluate the treatment effects and feasibility of an internet-delivered CBT-program adjusted for adolescents with functional abdominal pain and functional dyspepsia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 3, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

May 16, 2017

Status Verified

May 1, 2017

Enrollment Period

1.3 years

First QC Date

November 30, 2014

Last Update Submit

May 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Faces pain scale - R

    Change in pain intensity measured with a self-rating scale daily during 2 weeks at baseline and daily during 10th to 12th week post treatment for analysis of effect.The Faces Pain Scale is a self-report measure used to assess the intensity of children's pain. Faces have four faces representing least pain and most pain on equal intervals on a scale from 0-10. Its validity is supported by a strong positive correlation (r=0.93, N=76) with a visual analogue scale (VAS) measure in children aged 5-12 years. The metric for scoring (0-10) conforms closely to a linear interval scale.

    Baseline to 12 weeks.

Secondary Outcomes (18)

  • Faces pain scale - R

    Baseline to 9 months

  • Faces pain scale - R

    Weekly during treatment (treatment week 1-9).

  • Gastrointestinal Symptom Rating Scale-IBS Version (GSRS-IBS)

    Baseline to 10 weeks, baseline to 9 months

  • IBS-behavioral responses questionnaire (IBS-BRQ)

    Weekly during treatment (treatment week 1-9). Baseline to 10 weeks, baseline to 9 months.

  • Percieved Stress scale (PSS 10)

    Weekly during treatment (treatment week 1-9). Baseline to 10 weeks, baseline to 9 months.

  • +13 more secondary outcomes

Study Arms (1)

Internet-delivered CBT

EXPERIMENTAL

10 sessions of ICBT during 10 weeks for the adolescents. 5 session of parent training during 10 weeks for parents. Therapist support is provided at least once weekly through the platform developed for the purpose. Therapists are trained CBT-psychologists.

Behavioral: Internet-delivered CBT

Interventions

The Internet-delivered exposure treatment is based on the well-established internet-delivered CBT-treatment for IBS in adults, adapted for adolescents with FAP/FD and their parents. Main component in the treatment is exposure for symptoms. The purpose of the treatment is to reduce fearful and anxious responses to symptoms and lessen avoidance of symptoms in the adolescents, and to teach the parents how parental behavior can influence symptoms in children as well as how to support exposure. Detailed behaviour analysis is made for each individual and instruction is given on how to gradually expose to symptoms to lessen fear for symptoms and widen the behavioral repertoire.

Internet-delivered CBT

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • fulfilling Rome III-criteria for FAP or FD with:
  • a written diagnosis from patient's physician and negative required tests (Blood samples: C-reactive protein or erythrocyte sedimentation rate, Blood count and IgA-Transglutaminase. Stool: f-Calprotectin)
  • The Rome III questionnaire + clinical interview confirming the diagnosis

You may not qualify if:

  • Concurrent serious medical conditions
  • Concurrent serous psychiatric diagnosis
  • On-going psychological treatment
  • On-going abuse or severe parental psychiatric illness in the family
  • Lack of regular internet-access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BUP-CPF, CAP Research Center

Stockholm, Stockholms County, 11330, Sweden

Location

MeSH Terms

Conditions

Gastrointestinal DiseasesAbdominal PainDyspepsia

Condition Hierarchy (Ancestors)

Digestive System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Study Officials

  • Brjánn Ljótsson, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

November 30, 2014

First Posted

December 3, 2014

Study Start

March 1, 2015

Primary Completion

July 1, 2016

Study Completion

December 1, 2016

Last Updated

May 16, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations